Concepedia

Mark Du

MD

7

Publications

952

Citations

7

H-Index

2000

Active since

Affiliations

Indiana University Bloomington(Current)

Eli Lilly (United States)

Mark Du is an author at Indiana University Bloomington specializing in medicine, cancer research, and immunology.

ORCID

Top concepts

Publications per year

2000–2004

7

Publications

7

Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell Proliferation

Patrick Hwu, Mark Du, Réjean Lapointe et al. · The Journal of Immunology · 2000 · 741 citations · Full text

, , +17

Analysis of Transcription Factors Regulating Induction of Indoleamine 2,3-Dioxygenase by IFN- <i>gamma</i>

Mark Du, Walter D. Sotero-Esteva, Milton W. Taylor · Journal of Interferon & Cytokine Research · 2000 · 66 citations

Comparative characterization of two DEAD-box RNA helicases in superfamily II: human translation-initiation factor 4A and hepatitis C virus non-structural protein 3 (NS3) helicase

Mark Du, Robert B. Johnson, Xin-Lai Sun et al. · Biochemical Journal · 2002 · 41 citations · Full text

Identification of Novel Small-Molecule Inhibitors for Human Transketolase by High-Throughput Screening with Fluorescent Intensity (FLINT) Assay

Mark Du, Janet Sim, Lijuan Fang et al. · SLAS DISCOVERY · 2004 · 37 citations · Full text

PLK1 as a potential drug target in cancer therapy

Kee Chuan Goh, Haishan Wang, Niefang Yu et al. · Drug Development Research · 2004 · 25 citations · Full text

, , +12

Rows per page

1–5 of 7